Title | The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery. |
Publication Type | Journal Article |
Year of Publication | 2016 |
Authors | Toriyama, M, Lee, C, S Taylor, P, Duran, I, Cohn, DH, Bruel, A-L, Tabler, JM, Drew, K, Kelly, MR, Kim, S, Park, TJoo, Braun, DA, Pierquin, G, Biver, A, Wagner, K, Malfroot, A, Panigrahi, I, Franco, B, Al-Lami, HAdel, Yeung, Y, Choi, YJa, Duffourd, Y, Faivre, L, Rivière, J-B, Chen, J, Liu, KJ, Marcotte, EM, Hildebrandt, F, Thauvin-Robinet, C, Krakow, D, Jackson, PK, Wallingford, JB |
Corporate Authors | University of Washington Center for Mendelian Genomics |
Journal | Nat Genet |
Volume | 48 |
Issue | 6 |
Pagination | 648-56 |
Date Published | 2016 06 |
ISSN | 1546-1718 |
Keywords | Animals, Ciliopathies, Flagella, Humans, Mice, Mutation, Phenotype, Protein Binding, Protein Transport, Proteins |
Abstract | Cilia use microtubule-based intraflagellar transport (IFT) to organize intercellular signaling. Ciliopathies are a spectrum of human diseases resulting from defects in cilia structure or function. The mechanisms regulating the assembly of ciliary multiprotein complexes and the transport of these complexes to the base of cilia remain largely unknown. Combining proteomics, in vivo imaging and genetic analysis of proteins linked to planar cell polarity (Inturned, Fuzzy and Wdpcp), we identified and characterized a new genetic module, which we term CPLANE (ciliogenesis and planar polarity effector), and an extensive associated protein network. CPLANE proteins physically and functionally interact with the poorly understood ciliopathy-associated protein Jbts17 at basal bodies, where they act to recruit a specific subset of IFT-A proteins. In the absence of CPLANE, defective IFT-A particles enter the axoneme and IFT-B trafficking is severely perturbed. Accordingly, mutation of CPLANE genes elicits specific ciliopathy phenotypes in mouse models and is associated with ciliopathies in human patients. |
DOI | 10.1038/ng.3558 |
Alternate Journal | Nat. Genet. |
PubMed ID | 27158779 |
PubMed Central ID | PMC4978421 |
Grant List | MR/L017237/1 / / Medical Research Council / United Kingdom RC2 HL102923 / HL / NHLBI NIH HHS / United States U54 HG006493 / HG / NHGRI NIH HHS / United States UC2 HL102926 / HL / NHLBI NIH HHS / United States UC2 HL103010 / HL / NHLBI NIH HHS / United States UM1 HG006504 / HG / NHGRI NIH HHS / United States RC2 HL102926 / HL / NHLBI NIH HHS / United States DP1 GM106408 / GM / NIGMS NIH HHS / United States / HH / Howard Hughes Medical Institute / United States UL1 TR000124 / TR / NCATS NIH HHS / United States R01 GM086627 / GM / NIGMS NIH HHS / United States RC2 HL102924 / HL / NHLBI NIH HHS / United States R01 AR061485 / AR / NIAMS NIH HHS / United States R01 HL117164 / HL / NHLBI NIH HHS / United States R01 DK068306 / DK / NIDDK NIH HHS / United States R01 GM121565 / GM / NIGMS NIH HHS / United States R01 GM114276 / GM / NIGMS NIH HHS / United States UC2 HL102923 / HL / NHLBI NIH HHS / United States UC2 HL102924 / HL / NHLBI NIH HHS / United States UM1 HG006493 / HG / NHGRI NIH HHS / United States BB/K010492/1 / / Biotechnology and Biological Sciences Research Council / United Kingdom RC2 HL103010 / HL / NHLBI NIH HHS / United States R01 AR066124 / AR / NIAMS NIH HHS / United States R01 AR062651 / AR / NIAMS NIH HHS / United States R01 GM104853 / GM / NIGMS NIH HHS / United States RC2 HL102925 / HL / NHLBI NIH HHS / United States UC2 HL102925 / HL / NHLBI NIH HHS / United States F32 GM112495 / GM / NIGMS NIH HHS / United States |